These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 11010751

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antiplatelet drugs in cardiovascular prevention: stroke: acute phase and secondary prevention.
    Prescrire Int; 2000 Jun; 9(47):85-7. PubMed ID: 11010750
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
    Tay KH, Lip GY, Lane DA.
    Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial.
    Hart RG, Bhatt DL, Hacke W, Fox KA, Hankey GJ, Berger PB, Hu T, Topol EJ, CHARISMA Investigators.
    Cerebrovasc Dis; 2008 Mar; 25(4):344-7. PubMed ID: 18303254
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Atrial fibrillation and stroke prevention.
    Kakar P, Lip GY.
    Expert Rev Neurother; 2006 Oct; 6(10):1523-30. PubMed ID: 17078791
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.
    Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, Healey JS, Yusuf S, ACTIVE W Investigators.
    Circulation; 2008 Nov 11; 118(20):2029-37. PubMed ID: 18955670
    [Abstract] [Full Text] [Related]

  • 15. Dual antiplatelet therapy is not optimal for stroke prevention in patients with atrial fibrillation.
    Chamorro A.
    Int J Stroke; 2010 Feb 11; 5(1):28-9. PubMed ID: 20088990
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update].
    Pengo V, De Caterina R.
    Ital Heart J Suppl; 2001 Sep 11; 2(9):972-9. PubMed ID: 11675834
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness and safety of combined antiplatelet and anticoagulant therapy: a critical review of the evidence from randomized controlled trials.
    Paikin JS, Wright DS, Eikelboom JW.
    Blood Rev; 2011 May 11; 25(3):123-9. PubMed ID: 21354678
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.